Liposome-based delivery of biological drugs

KT Magar, GF Boafo, X Li, Z Chen, W He - Chinese Chemical Letters, 2022 - Elsevier
KT Magar, GF Boafo, X Li, Z Chen, W He
Chinese Chemical Letters, 2022Elsevier
Biological drugs are attracting tremendous attention in disease treatment. However, their
application is significantly limited by their inherent properties, such as high hydrophilicity,
poor membrane-permeability, low stability, and larger size. Liposome-based drug delivery
systems are emerging as promising tools to improve their delivery, owing to their ability to
reduce toxicity, improve bioavailability, and enhance the therapeutic efficacy of the drug by
optimizing delivery to the specific target site. Here, we reviewed the types of liposomes and …
Abstract
Biological drugs are attracting tremendous attention in disease treatment. However, their application is significantly limited by their inherent properties, such as high hydrophilicity, poor membrane-permeability, low stability, and larger size. Liposome-based drug delivery systems are emerging as promising tools to improve their delivery, owing to their ability to reduce toxicity, improve bioavailability, and enhance the therapeutic efficacy of the drug by optimizing delivery to the specific target site. Here, we reviewed the types of liposomes and their applications as carriers for biological drugs to treat various diseases, emphasized the commercial products, and ultimately provided perspectives in this field.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果